BACKGROUND: Myelomeningocele (MM) is a condition that is responsible for considerable morbidity in the pediatric population. A significant proportion of the morbidity related to MM is attributable to hydrocephalus and the surgical management thereof. Postnatal repair remains the most common form of treatment; however, increased rates of prenatal diagnosis, advances in fetal surgery, and a hypothesis that neural injury continues in utero until the MM defect is repaired have led to the development and evaluation of prenatal surgery as a means to improve outcomes in afflicted infants. OBJECTIVE: The objective of this guideline is to systematically evaluate the literature to determine whether there is a difference in the proportion of patients who develop shuntdependent hydrocephalus in infants who underwent prenatal MM repair compared to infants who had postnatal repair. METHODS: The Guidelines Task Force developed search terms and strategies used to search PubMed and Embase for relevant literature published between 1966 and September 2016. Strict inclusion/exclusion criteria were used to screen abstracts and to develop a list of relevant articles for full-text review. Full-text articles were then reviewed, and when appropriate, included as evidence. RESULTS: A total of 87 abstracts were identified and reviewed by 3 independent reviewers. Thirty-nine full-text articles were selected for analysis. Three studies met selection criteria and were included in the evidence table. CONCLUSION: Class I evidence from 1 study and class III evidence from 2 studies suggest that, in comparison to postnatal repair, prenatal surgery for MM reduces the risk of developing shunt-dependent hydrocephalus. Therefore, prenatal repair of MM is recommended for those fetuses who meet specific criteria for prenatal surgery to reduce the risk of developing shunt-dependent hydrocephalus (level I). Differences between prenatal and postnatal repair with respect to the requirement for permanent cerebrospinal fluid diversion should be considered alongside other relevant maternal and fetal factors when deciding upon a preferred method of MM closure.
Conventional treatment of MM has been to perform a postnatal repair within 48 h after birth. After repair of the defect, neurosurgeons must remain vigilant about recognizing and treating hydrocephalus, which is a frequent comorbidity in MM patients.
Early observations regarding the effect of prenatal MM repair on outcomes were published in the 1990s, [4] [5] [6] and demonstrated that some fetuses who received in utero repair had improved functional outcomes and a lower requirement for shunt placement after birth. Outcomes in subsequent larger cohorts of infants who were treated with prenatal surgery as fetuses, when compared to historical controls treated with postnatal repair, continued to demonstrate evidence of improved patient functional outcomes and a lower incidence of shunt-dependent hydrocephalus. 6, 7 Prenatal repair of MM involves serious and permanent risks for mother and fetus. Fetal demise, preterm labor, premature rupture of membranes, and maternal infection are of particular concern. The Management of Myelomeningocele Study (MOMS) trial was the first and only randomized comparison of the safety and efficacy of prenatal MM repair with respect to conventional postnatal surgery. 8 No evidence-based guidelines regarding the role of prenatal surgery in the management of MM were published prior to this guideline. Given the potentially important risks and benefits to the infant and mother, the authors felt that it was important to evaluate the literature in a systematic way in an effort to guide clinicians in the management of this challenging disorder. In this guideline, the authors specifically address whether the incidence of shunt-dependent hydrocephalus differs between fetuses with MM who underwent prenatal vs infants with MM who underwent postnatal repair.
METHODS
The task force members collaborated with a medical librarian to search the PubMed and Embase databases for the period from 1966 to September 2016. The literature search yielded 71 abstracts. To supplement the results of the electronic search, an additional 16 abstracts/articles were identified after manually screening the bibliographies of all retrieved publications. The task force selected 39 full-text articles for review. Of these, 36 were rejected for not meeting inclusion criteria or for being off-topic. Three were selected for systematic review and inclusion into the evidence tables. [9] [10] [11] The quality of evidence was rated using an evidence hierarchy for therapeutic studies. Demonstrating the highest degree of clinical certainty, class I evidence is used to support recommendations of the strongest type, defined as level I recommendations. Level II recommendations reflect a moderate degree of clinical certainty and are supported by class II evidence. Level III recommendations denote clinical uncertainty supported by class III evidence.
Additional information about the methods utilized in this systematic review is provided in the introduction and methodology chapter (https://www.cns.org/guidelines/guidelines-spina-bifida-chapter-1). 
RECOMMENDATIONS

DISCUSSION
There appears to be evidence that prenatal MM repair is effective in reducing the proportion of infants who require CSF shunt placement when compared to infants who are treated using conventional postnatal repair. [8] [9] [10] [11] The most robust data come from a single randomized controlled trial, although there is other evidence in support of the direction and magnitude of the observed effect. Based on a thorough systematic review of the literature, this guideline can provide a level I recommendation that prenatal repair of MM is recommended for those fetuses that meet maternal and fetal MOMs inclusion criteria to reduce the risk of developing shunt-dependent hydrocephalus. Differences between prenatal and postnatal repair with respect to the requirement for permanent CSF diversion should be considered alongside other relevant maternal and fetal factors, such as the likelihood of preterm delivery, when deciding upon a preferred method of MM closure.
Biases inherent to small cases series limit the quality of the data they can provide. Nevertheless, the foundation of the current recommendation can be somewhat strengthened if these case SHUNT-DEPENDENT HYDROCEPHALUS series provide data which are congruent with more methodologically rigorous studies. Several case series, with or without the use of historical controls, were identified during the process of initial abstract screening. Although they did not meet the criteria for inclusion into the evidence table, they do provide some corroborating information relevant to this recommendation.
Two studies employed historical controls treated with postnatal repair as a benchmark to evaluate the effect of prenatal MM closure on the requirement for shunt placement. 6, 7 Both of these studies provided supportive evidence in favor of the magnitude and direction of the effect observed in the subsequently completed MOMS.
Several retrospective, noncomparative cases series provided evidence regarding the proportion of patients who required CSF shunt placement following either postnatal [12] [13] [14] [15] [16] [17] or prenatal 18, 19 MM repair. The results of these small studies report shunt placement rates generally around 80% in postnatal repair infants and 50% in prenatal repair patients, largely in keeping with the eventual results of the MOMS trial. 8, 10 As emphasized by the MOMS investigators, the lack of uniform criteria for the initiation of permanent CSF diversion therapy can significantly influence the likelihood of this outcome. To illustrate this point further, by using rigorous and "stringent" criteria for the placement of a CSF shunt, clinicians at Great Ormond Street Hospital were able to demonstrate that the shunt insertion rate in a contemporary cohort who underwent postnatal MM repair could be lower than previously reported and comparable to that following in utero repair. 14 Despite the strength of the recommendation, readers of this guideline should be cognizant of important caveats regarding generalizability. This recommendation is based upon data from a very small number of patients because of the highly restrictive criteria that are used to judge whether an individual is appropriate for prenatal intervention. As a corollary, the recommendation is only applicable to patients who are considered potential candidates for prenatal MM repair based upon those same criteria. In addition, there is uncertainty regarding whether the documented effect of prenatal MM repair on the incidence of shunt dependent hydrocephalus can be replicated outside of the highly experienced centers involved in MOMS. This issue further limits the potential impact of this recommendation to the general MM population.
CONCLUSION
Class I evidence from 1 study and class III evidence from 2 studies suggest that in comparison to postnatal repair, prenatal surgery for MM reduces the risk of developing shuntdependent hydrocephalus. Therefore, prenatal repair of MM is recommended for those infants who meet specific criteria for prenatal surgery as fetuses to reduce the risk of developing shunt-dependent hydrocephalus (level I). Differences between prenatal and postnatal repair with respect to the requirement for permanent CSF diversion should be considered alongside other relevant maternal and fetal factors when deciding upon a preferred method of MM closure.
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